type here...

CATEGORIES

Medication

LATEST

1234Page 4 of 4

TRENDING

EDITORS CHOICE

The Trauma of Witnessing Charlie Kirk’s Murder and PTSD

Pat Farrell PhD -
The psychological effects of public space shootings extend beyond physical harm because they create a broad psychological impact on everyone present at the scene....

Psilocybin as an Antidepressant for Cancer Patients Who Are Not Depressed

James Coyne -
Research concerning the role of psychedelics in mental health treatment and its superb publicity campaign depends on millions of dollars raised by venture capitalists.

The Future of Cardiovascular Disease Prevention: Insights from Drs. Eric Topol and Pradeep Natarajan

Christopher Nial -
While LDL cholesterol remains a crucial target in cardiovascular prevention, it is important to look beyond this traditional marker.

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston -
The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories